If I switch to Wegovy, do I need to start from the lowest dose
La evidencia clnica del frmaco est basada en el programa STEP (Semaglutide Treatment Effect in People with Obesity, por sus siglas en ingls), un programa de desarrollo clnico fase 3a/3b de semaglutida 2,4 mg subcutnea semanal en personas con sobrepeso (IMC entre 27 kg/m2 y 30 kg/m2 y al menos una comorbilidad relacionada con el peso) u obesidad
Available from: Heber D, Greenway FL, Kaplan LM, et al
Theyve long been studied as a potential solution for premature ejaculation, and theyve had a lot of success in that department.9 But they also offer more potential side effects than the topical anesthetics youll find in the wipes and sprays
The titration schedule might also vary depending on your primary concern
Patients should also be aware that rapid improvement in glucose control can transiently worsen diabetic retinopathy